View Future GrowthCosnine 과거 순이익 실적과거 기준 점검 0/6Cosnine은 연평균 4%의 비율로 수입이 증가해 온 반면, Electronic 산업은 연평균 8.1%의 비율로 증가했습니다. 매출은 연평균 32%의 비율로 감소했습니다.핵심 정보3.99%순이익 성장률48.23%주당순이익(EPS) 성장률Electronic 산업 성장률21.63%매출 성장률-31.99%자기자본이익률-19.57%순이익률-62.70%최근 순이익 업데이트30 Jun 2024최근 과거 실적 업데이트Reported Earnings • Apr 08Full year 2021 earnings released: ₩242 loss per share (vs ₩443 loss in FY 2020)Full year 2021 results: ₩242 loss per share (up from ₩443 loss in FY 2020). Revenue: ₩12.5b (down 40% from FY 2020). Net loss: ₩9.56b (loss narrowed 7.2% from FY 2020). Over the last 3 years on average, earnings per share has increased by 127% per year but the company’s share price has fallen by 31% per year, which means it is significantly lagging earnings.Reported Earnings • Nov 17Third quarter 2021 earnings released: ₩9.61 loss per share (vs ₩39.00 loss in 3Q 2020)The company reported a decent third quarter result with reduced losses and improved control over expenses, although revenues were weaker. Third quarter 2021 results: Revenue: ₩2.75b (down 16% from 3Q 2020). Net loss: ₩392.5m (loss narrowed 54% from 3Q 2020). Over the last 3 years on average, earnings per share has increased by 101% per year but the company’s share price has fallen by 30% per year, which means it is significantly lagging earnings.모든 업데이트 보기Recent updates공시 • Mar 17Cosnine Co., Ltd., Annual General Meeting, Mar 31, 2026Cosnine Co., Ltd., Annual General Meeting, Mar 31, 2026, at 09:01 Tokyo Standard Time. Location: conference room, 27, hagunsandan 2-ro, yangchon-eup, gyeonggi-do, gimpo South Korea공시 • Mar 18Cosnine Co., Ltd., Annual General Meeting, Mar 31, 2025Cosnine Co., Ltd., Annual General Meeting, Mar 31, 2025, at 09:00 Tokyo Standard Time. Location: conference room, 27, hagunsandan 2-ro, yangchon-eup, gyeonggi-do, gimpo South Korea분석 기사 • Mar 22Is Cosnine (KOSDAQ:082660) Using Debt In A Risky Way?Legendary fund manager Li Lu (who Charlie Munger backed) once said, 'The biggest investment risk is not the volatility...공시 • Aug 01Cosnine Co., Ltd. announced that it has received KRW 4 billion in funding from Sangsangin Savings Bank, Investment Arm, Sangsangin Plus Savings Bank, Investment ArmOn July 31, 2023, Cosnine Co., Ltd. closed the transaction.Board Change • Mar 13No independent directorsNo new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 5 experienced directors. No highly experienced directors. No independent directors (5 non-independent directors). was the last director to join the board, commencing their role in . The following issues are considered to be risks according to the Simply Wall St Risk Model: Lack of independent directors. Insufficient board refreshment.Board Change • Nov 16No independent directorsNo new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 5 experienced directors. No highly experienced directors. No independent directors (5 non-independent directors). was the last director to join the board, commencing their role in . The following issues are considered to be risks according to the Simply Wall St Risk Model: Lack of independent directors. Insufficient board refreshment.Board Change • Apr 27No independent directorsNo new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 5 experienced directors. No highly experienced directors. No independent directors (5 non-independent directors). was the last director to join the board, commencing their role in . The following issues are considered to be risks according to the Simply Wall St Risk Model: Lack of independent directors. Insufficient board refreshment.Reported Earnings • Apr 08Full year 2021 earnings released: ₩242 loss per share (vs ₩443 loss in FY 2020)Full year 2021 results: ₩242 loss per share (up from ₩443 loss in FY 2020). Revenue: ₩12.5b (down 40% from FY 2020). Net loss: ₩9.56b (loss narrowed 7.2% from FY 2020). Over the last 3 years on average, earnings per share has increased by 127% per year but the company’s share price has fallen by 31% per year, which means it is significantly lagging earnings.Reported Earnings • Nov 17Third quarter 2021 earnings released: ₩9.61 loss per share (vs ₩39.00 loss in 3Q 2020)The company reported a decent third quarter result with reduced losses and improved control over expenses, although revenues were weaker. Third quarter 2021 results: Revenue: ₩2.75b (down 16% from 3Q 2020). Net loss: ₩392.5m (loss narrowed 54% from 3Q 2020). Over the last 3 years on average, earnings per share has increased by 101% per year but the company’s share price has fallen by 30% per year, which means it is significantly lagging earnings.공시 • Feb 26Cosnine Co., Ltd. announced that it has received KRW 6.0116 billion in funding from Icure Pharmaceutical IncorporationOn February 25, 2021, Cosnine Co., Ltd. (KOSDAQ:A082660) closed the transaction.공시 • Feb 11Cosnine Co., Ltd. announced that it expects to receive KRW 6.0116 billion in fundingCosnine Co., Ltd. (KOSDAQ:A082660) announced a private placement of 4,520,000 common share at an issue price of KRW 1,330 per share for gross proceeds of KRW 6,011,600,000 on February 10, 2021. The face value of the shares to be issued is KRW 500 per share. The company will raise funds through third party allocation method. The shares to be issued will have a hold period of one year, post the closing. The payment date is on February 25, 2021. The transaction has been approved by the board of directors of the company.Is New 90 Day High Low • Jan 18New 90-day low: ₩1,460The company is down 11% from its price of ₩1,640 on 20 October 2020. The South Korean market is up 30% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Electronic industry, which is up 45% over the same period.공시 • Dec 04Cosnine Co., Ltd. announced that it has received KRW 4 billion in funding from Icure Pharmaceutical IncorporationOn December 3, 2020, Cosnine Co., Ltd. (KOSDAQ:A082660) closed the transaction.공시 • Nov 05Cosnine Co., Ltd. announced that it expects to receive KRW 4 billion in funding from Icure Pharmaceutical Incorporation and another investorCosnine Co., Ltd. (KOSDAQ:A082660) announced a private placement of series 20 unregistered coupon non-guaranteed private convertible bonds for gross proceeds of KRW 4,000,000,000 on November 03, 2020. The transaction will include participation from Icure Pharmaceutical Incorporation (KOSDAQ:A175250) and Trevia Inc. for KRW 2,000,000,000. The bonds do not carry any coupon and yield to maturity of 4% and will mature on November 30, 2023. The bonds are 100% convertible into 2,461,538 common shares representing 8.70% of the total number of shares of the company at a conversion price of KRW 1,625 per share. The conversion period of the bonds will start on November 30, 2021 and ends on October 30, 2023. The subscription date and the payment date are on November 3, 2020 and November 30, 2020. The transaction has been approved by the board of directors of the company.공시 • Sep 30Cosnine Co., Ltd. announced that it has received KRW 4.99954 billion in fundingOn September 29, 2020, Cosnine Co., Ltd. (KOSDAQ:A082660) closed the transaction.공시 • Sep 26Cosnine Co., Ltd. announced that it expects to receive KRW 999.99879 million in fundingCosnine Co., Ltd. (KOSDAQ:A082660) announced a private placement of 709,219 common shares at a price of KRW 1,410 per share for the gross proceeds of KRW 999,998,790 on September 25, 2020. The transaction will include participation from Bioline Value Investment Fund. The shares issued in the transaction have a par value of KRW 500 per share. The security will be issued at premium of 10%. The transaction will take place through third party allotment. The securities are subject to a hold period of 1 year. The transaction was approved by the board of directors of the company. The transaction is expected to close on October 8, 2020.Is New 90 Day High Low • Sep 22New 90-day high: ₩1,630The company is up 17% from its price of ₩1,395 on 24 June 2020. The South Korean market is up 13% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Electronic industry, which is up 14% over the same period.공시 • Sep 22Cosnine Co., Ltd. announced that it expects to receive KRW 4.99954 billion in fundingCosnine Co., Ltd. (KOSDAQ:A082660) announced a private placement of 3,731,000 common shares at a price of KRW 1,340 per share for the gross proceeds of KRW 4,999,540,000 on September 21, 2020. The transaction will include participation from Bioline Value Investment Fund. The shares issued in the transaction have a par value of KRW 500 per share. The security will be issued at premium of 10%. The transaction will take place through third party allotment. The securities are subject to a hold period of 1 year. The transaction was approved by the board of directors of the company. The transaction is expected to close on September 29, 2020.공시 • Sep 11Cosnine Co., Ltd. has completed a Follow-on Equity Offering in the amount of KRW 999.99985 million.Cosnine Co., Ltd. has completed a Follow-on Equity Offering in the amount of KRW 999.99985 million. Security Name: Common Stock Security Type: Common Stock Securities Offered: 778,210 Price\Range: KRW 1285 Transaction Features: Subsequent Direct Listing공시 • Aug 15Cosnine Co., Ltd. announced that it expects to receive KRW 2 billion in funding from Sangsangin Savings Bank, Investment ArmCosnine Co., Ltd. (KOSDAQ:A082660) announced a private placement of series 19 registered non-guaranteed private convertible bonds for gross proceeds of KRW 2,000,000,000 on August 14, 2020. The bonds carry a coupon rate of 5% and interest rate to maturity of 7% and will mature on August 18, 2023. The bonds are 100% convertible into 1,594,896 common shares representing 7.45% of the total number of shares of the company at a conversion price of KRW 1,254 per share. The conversion period of the bonds will start on August 18, 2021 and ends on July 18, 2023. The transaction will include participation from returning investor Sangsangin Savings Bank, Investment Arm. The transaction has been approved by the board of directors of the company. The subscription date of the transaction is on the same day and the payment date is on August 18, 2020.공시 • Jul 17+ 1 more updateCosnine Co., Ltd. announced that it expects to receive KRW 2 billion in fundingCosnine Co., Ltd (KOSDAQ:A082660) announced a private placement to issue series 18 bearer mortgage convertible bond of KRW 2,000,000,000 on July 9, 2020. The transaction will include participation from Markers Investment Co., Ltd. for KRW 1,000,000,000, Jo Sung Woo and Dohyung Lim for KRW 300,000,000 each, and Dongik Kim for KRW 400,000,000. The bonds will carry rate of interest of 4% and will mature on July 10, 2023. The bonds are convertible into 1,543,209 common shares of the company at a conversion price of KRW 1,296 per share. The conversion period will start at July 10, 2021 and ends on June 10, 2023. The transaction is expected to close on July 10, 2020. The transaction has been approved by the board of directors of the company.매출 및 비용 세부 내역Cosnine가 돈을 벌고 사용하는 방법. 최근 발표된 LTM 실적 기준.순이익 및 매출 추이KOSDAQ:A082660 매출, 비용 및 순이익 (KRW Millions)날짜매출순이익일반관리비연구개발비30 Jun 2410,115-6,3433,9231,01131 Mar 249,612-6,4754,47193531 Dec 239,608-5,8785,16385530 Sep 239,499-8,8914,74275030 Jun 2310,141-7,8834,86670131 Mar 239,401-9,0214,78368731 Dec 228,998-10,7684,79069230 Sep 229,264-13,3976,69166130 Jun 229,193-12,0835,76572031 Mar 229,569-12,4416,10881231 Dec 2112,545-10,7685,70393130 Sep 2114,357-10,9094,8401,03630 Jun 2114,942-11,1864,95296631 Mar 2119,731-11,2473,99186231 Dec 2021,016-10,3053,88684330 Sep 2026,290-7,1853,42360930 Jun 2028,485-8,3133,82464731 Mar 2023,790-7,0173,99152131 Dec 1918,357-7,4913,75523830 Sep 1931,622-11,4034,88123930 Jun 1948,310-11,0604,7414531 Mar 1965,527-9,3214,572031 Dec 1887,007-13,3494,755030 Sep 1821,109-5,6762,006-5130 Jun 1850,304-6,2392,723-2931 Mar 1873,173-8,4023,698-2531 Dec 1795,607-10,3564,738030 Sep 17184,927-17,9788,05930030 Jun 17183,925-15,5938,44147131 Mar 17197,133-13,0268,94573831 Dec 16207,266-6,5088,8801,06830 Sep 16239,333-2498,7301,20530 Jun 16261,6997039,0831,21231 Mar 16252,840-6179,0611,10931 Dec 15263,6471269,52596330 Sep 15259,8291,77410,25280630 Jun 15280,0832,68810,31991531 Mar 15314,0613,64410,6371,09331 Dec 14340,1815,85511,2871,25930 Sep 14362,4187,06812,0411,36230 Jun 14355,1315,94513,4451,41131 Mar 14361,9528,04015,4151,35431 Dec 13329,5616,68515,5651,261양질의 수익: A082660 은(는) 현재 수익성이 없습니다.이익 마진 증가: A082660는 현재 수익성이 없습니다.잉여현금흐름 대비 순이익 분석과거 순이익 성장 분석수익추이: A082660는 수익성이 없지만 지난 5년 동안 연평균 4%의 속도로 손실을 줄였습니다.성장 가속화: 현재 수익성이 없어 지난 1년간 A082660의 수익 성장률을 5년 평균과 비교할 수 없습니다.수익 대 산업: A082660은 수익성이 없어 지난 해 수익 성장률을 Electronic 업계(-0.9%)와 비교하기 어렵습니다.자기자본이익률높은 ROE: A082660는 현재 수익성이 없으므로 자본 수익률이 음수(-19.57%)입니다.총자산이익률투하자본수익률우수한 과거 실적 기업을 찾아보세요7D1Y7D1Y7D1YTech 산업에서 과거 실적이 우수한 기업.View Financial Health기업 분석 및 재무 데이터 상태데이터최종 업데이트 (UTC 시간)기업 분석2024/11/03 03:17종가2024/08/07 00:00수익2024/06/30연간 수익2023/12/31데이터 소스당사의 기업 분석에 사용되는 데이터는 S&P Global Market Intelligence LLC에서 제공됩니다. 아래 데이터는 이 보고서를 생성하기 위해 분석 모델에서 사용됩니다. 데이터는 정규화되므로 소스가 제공된 후 지연이 발생할 수 있습니다.패키지데이터기간미국 소스 예시 *기업 재무제표10년손익계산서현금흐름표대차대조표SEC 양식 10-KSEC 양식 10-Q분석가 컨센서스 추정치+3년재무 예측분석가 목표주가분석가 리서치 보고서Blue Matrix시장 가격30년주가배당, 분할 및 기타 조치ICE 시장 데이터SEC 양식 S-1지분 구조10년주요 주주내부자 거래SEC 양식 4SEC 양식 13D경영진10년리더십 팀이사회SEC 양식 10-KSEC 양식 DEF 14A주요 개발10년회사 공시SEC 양식 8-K* 미국 증권에 대한 예시이며, 비(非)미국 증권에는 해당 국가의 규제 서식 및 자료원을 사용합니다.별도로 명시되지 않는 한 모든 재무 데이터는 연간 기간을 기준으로 하지만 분기별로 업데이트됩니다. 이를 TTM(최근 12개월) 또는 LTM(지난 12개월) 데이터라고 합니다. 자세히 알아보기.분석 모델 및 스노우플레이크이 보고서를 생성하는 데 사용된 분석 모델에 대한 자세한 내용은 당사의 Github 페이지에서 확인하실 수 있습니다. 또한 보고서 활용 방법에 대한 가이드와 YouTube 튜토리얼도 제공합니다.Simply Wall St 분석 모델을 설계하고 구축한 세계적 수준의 팀에 대해 알아보세요.산업 및 섹터 지표산업 및 섹터 지표는 Simply Wall St가 6시간마다 계산하며, 프로세스에 대한 자세한 내용은 Github에서 확인할 수 있습니다.분석가 소스Cosnine Co., Ltd.는 1명의 분석가가 다루고 있습니다. 이 중 0명의 분석가가 우리 보고서에 입력 데이터로 사용되는 매출 또는 수익 추정치를 제출했습니다. 분석가의 제출 자료는 하루 종일 업데이트됩니다.분석가기관Mina LeeiM Securities
Reported Earnings • Apr 08Full year 2021 earnings released: ₩242 loss per share (vs ₩443 loss in FY 2020)Full year 2021 results: ₩242 loss per share (up from ₩443 loss in FY 2020). Revenue: ₩12.5b (down 40% from FY 2020). Net loss: ₩9.56b (loss narrowed 7.2% from FY 2020). Over the last 3 years on average, earnings per share has increased by 127% per year but the company’s share price has fallen by 31% per year, which means it is significantly lagging earnings.
Reported Earnings • Nov 17Third quarter 2021 earnings released: ₩9.61 loss per share (vs ₩39.00 loss in 3Q 2020)The company reported a decent third quarter result with reduced losses and improved control over expenses, although revenues were weaker. Third quarter 2021 results: Revenue: ₩2.75b (down 16% from 3Q 2020). Net loss: ₩392.5m (loss narrowed 54% from 3Q 2020). Over the last 3 years on average, earnings per share has increased by 101% per year but the company’s share price has fallen by 30% per year, which means it is significantly lagging earnings.
공시 • Mar 17Cosnine Co., Ltd., Annual General Meeting, Mar 31, 2026Cosnine Co., Ltd., Annual General Meeting, Mar 31, 2026, at 09:01 Tokyo Standard Time. Location: conference room, 27, hagunsandan 2-ro, yangchon-eup, gyeonggi-do, gimpo South Korea
공시 • Mar 18Cosnine Co., Ltd., Annual General Meeting, Mar 31, 2025Cosnine Co., Ltd., Annual General Meeting, Mar 31, 2025, at 09:00 Tokyo Standard Time. Location: conference room, 27, hagunsandan 2-ro, yangchon-eup, gyeonggi-do, gimpo South Korea
분석 기사 • Mar 22Is Cosnine (KOSDAQ:082660) Using Debt In A Risky Way?Legendary fund manager Li Lu (who Charlie Munger backed) once said, 'The biggest investment risk is not the volatility...
공시 • Aug 01Cosnine Co., Ltd. announced that it has received KRW 4 billion in funding from Sangsangin Savings Bank, Investment Arm, Sangsangin Plus Savings Bank, Investment ArmOn July 31, 2023, Cosnine Co., Ltd. closed the transaction.
Board Change • Mar 13No independent directorsNo new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 5 experienced directors. No highly experienced directors. No independent directors (5 non-independent directors). was the last director to join the board, commencing their role in . The following issues are considered to be risks according to the Simply Wall St Risk Model: Lack of independent directors. Insufficient board refreshment.
Board Change • Nov 16No independent directorsNo new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 5 experienced directors. No highly experienced directors. No independent directors (5 non-independent directors). was the last director to join the board, commencing their role in . The following issues are considered to be risks according to the Simply Wall St Risk Model: Lack of independent directors. Insufficient board refreshment.
Board Change • Apr 27No independent directorsNo new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 5 experienced directors. No highly experienced directors. No independent directors (5 non-independent directors). was the last director to join the board, commencing their role in . The following issues are considered to be risks according to the Simply Wall St Risk Model: Lack of independent directors. Insufficient board refreshment.
Reported Earnings • Apr 08Full year 2021 earnings released: ₩242 loss per share (vs ₩443 loss in FY 2020)Full year 2021 results: ₩242 loss per share (up from ₩443 loss in FY 2020). Revenue: ₩12.5b (down 40% from FY 2020). Net loss: ₩9.56b (loss narrowed 7.2% from FY 2020). Over the last 3 years on average, earnings per share has increased by 127% per year but the company’s share price has fallen by 31% per year, which means it is significantly lagging earnings.
Reported Earnings • Nov 17Third quarter 2021 earnings released: ₩9.61 loss per share (vs ₩39.00 loss in 3Q 2020)The company reported a decent third quarter result with reduced losses and improved control over expenses, although revenues were weaker. Third quarter 2021 results: Revenue: ₩2.75b (down 16% from 3Q 2020). Net loss: ₩392.5m (loss narrowed 54% from 3Q 2020). Over the last 3 years on average, earnings per share has increased by 101% per year but the company’s share price has fallen by 30% per year, which means it is significantly lagging earnings.
공시 • Feb 26Cosnine Co., Ltd. announced that it has received KRW 6.0116 billion in funding from Icure Pharmaceutical IncorporationOn February 25, 2021, Cosnine Co., Ltd. (KOSDAQ:A082660) closed the transaction.
공시 • Feb 11Cosnine Co., Ltd. announced that it expects to receive KRW 6.0116 billion in fundingCosnine Co., Ltd. (KOSDAQ:A082660) announced a private placement of 4,520,000 common share at an issue price of KRW 1,330 per share for gross proceeds of KRW 6,011,600,000 on February 10, 2021. The face value of the shares to be issued is KRW 500 per share. The company will raise funds through third party allocation method. The shares to be issued will have a hold period of one year, post the closing. The payment date is on February 25, 2021. The transaction has been approved by the board of directors of the company.
Is New 90 Day High Low • Jan 18New 90-day low: ₩1,460The company is down 11% from its price of ₩1,640 on 20 October 2020. The South Korean market is up 30% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Electronic industry, which is up 45% over the same period.
공시 • Dec 04Cosnine Co., Ltd. announced that it has received KRW 4 billion in funding from Icure Pharmaceutical IncorporationOn December 3, 2020, Cosnine Co., Ltd. (KOSDAQ:A082660) closed the transaction.
공시 • Nov 05Cosnine Co., Ltd. announced that it expects to receive KRW 4 billion in funding from Icure Pharmaceutical Incorporation and another investorCosnine Co., Ltd. (KOSDAQ:A082660) announced a private placement of series 20 unregistered coupon non-guaranteed private convertible bonds for gross proceeds of KRW 4,000,000,000 on November 03, 2020. The transaction will include participation from Icure Pharmaceutical Incorporation (KOSDAQ:A175250) and Trevia Inc. for KRW 2,000,000,000. The bonds do not carry any coupon and yield to maturity of 4% and will mature on November 30, 2023. The bonds are 100% convertible into 2,461,538 common shares representing 8.70% of the total number of shares of the company at a conversion price of KRW 1,625 per share. The conversion period of the bonds will start on November 30, 2021 and ends on October 30, 2023. The subscription date and the payment date are on November 3, 2020 and November 30, 2020. The transaction has been approved by the board of directors of the company.
공시 • Sep 30Cosnine Co., Ltd. announced that it has received KRW 4.99954 billion in fundingOn September 29, 2020, Cosnine Co., Ltd. (KOSDAQ:A082660) closed the transaction.
공시 • Sep 26Cosnine Co., Ltd. announced that it expects to receive KRW 999.99879 million in fundingCosnine Co., Ltd. (KOSDAQ:A082660) announced a private placement of 709,219 common shares at a price of KRW 1,410 per share for the gross proceeds of KRW 999,998,790 on September 25, 2020. The transaction will include participation from Bioline Value Investment Fund. The shares issued in the transaction have a par value of KRW 500 per share. The security will be issued at premium of 10%. The transaction will take place through third party allotment. The securities are subject to a hold period of 1 year. The transaction was approved by the board of directors of the company. The transaction is expected to close on October 8, 2020.
Is New 90 Day High Low • Sep 22New 90-day high: ₩1,630The company is up 17% from its price of ₩1,395 on 24 June 2020. The South Korean market is up 13% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Electronic industry, which is up 14% over the same period.
공시 • Sep 22Cosnine Co., Ltd. announced that it expects to receive KRW 4.99954 billion in fundingCosnine Co., Ltd. (KOSDAQ:A082660) announced a private placement of 3,731,000 common shares at a price of KRW 1,340 per share for the gross proceeds of KRW 4,999,540,000 on September 21, 2020. The transaction will include participation from Bioline Value Investment Fund. The shares issued in the transaction have a par value of KRW 500 per share. The security will be issued at premium of 10%. The transaction will take place through third party allotment. The securities are subject to a hold period of 1 year. The transaction was approved by the board of directors of the company. The transaction is expected to close on September 29, 2020.
공시 • Sep 11Cosnine Co., Ltd. has completed a Follow-on Equity Offering in the amount of KRW 999.99985 million.Cosnine Co., Ltd. has completed a Follow-on Equity Offering in the amount of KRW 999.99985 million. Security Name: Common Stock Security Type: Common Stock Securities Offered: 778,210 Price\Range: KRW 1285 Transaction Features: Subsequent Direct Listing
공시 • Aug 15Cosnine Co., Ltd. announced that it expects to receive KRW 2 billion in funding from Sangsangin Savings Bank, Investment ArmCosnine Co., Ltd. (KOSDAQ:A082660) announced a private placement of series 19 registered non-guaranteed private convertible bonds for gross proceeds of KRW 2,000,000,000 on August 14, 2020. The bonds carry a coupon rate of 5% and interest rate to maturity of 7% and will mature on August 18, 2023. The bonds are 100% convertible into 1,594,896 common shares representing 7.45% of the total number of shares of the company at a conversion price of KRW 1,254 per share. The conversion period of the bonds will start on August 18, 2021 and ends on July 18, 2023. The transaction will include participation from returning investor Sangsangin Savings Bank, Investment Arm. The transaction has been approved by the board of directors of the company. The subscription date of the transaction is on the same day and the payment date is on August 18, 2020.
공시 • Jul 17+ 1 more updateCosnine Co., Ltd. announced that it expects to receive KRW 2 billion in fundingCosnine Co., Ltd (KOSDAQ:A082660) announced a private placement to issue series 18 bearer mortgage convertible bond of KRW 2,000,000,000 on July 9, 2020. The transaction will include participation from Markers Investment Co., Ltd. for KRW 1,000,000,000, Jo Sung Woo and Dohyung Lim for KRW 300,000,000 each, and Dongik Kim for KRW 400,000,000. The bonds will carry rate of interest of 4% and will mature on July 10, 2023. The bonds are convertible into 1,543,209 common shares of the company at a conversion price of KRW 1,296 per share. The conversion period will start at July 10, 2021 and ends on June 10, 2023. The transaction is expected to close on July 10, 2020. The transaction has been approved by the board of directors of the company.